Expression of Smad6 and Smad7 in Pancreatic Cancer

LI Ke,LU Xinghua
DOI: https://doi.org/10.3969/j.issn.1008-7125.2005.06.003
2005-01-01
Abstract:The abnormality of transforming growth taetor (TGF)-β signaling pathway is an important factor in the pathogenesis of pancreatic cancer of which Smad proteins are key molecules, however, there are few articles focused on the changes of Smad6 and Smad7 in pancreatic cancer and their results are inconsistent. Aims: To study the expression of Smad6 and Smad7 in pancreatic cancer and their relations to patients' clinicopathological characteristics, so as to in- vestigate the possible mechanism of Smad6 and Smad7 in the cancer development. Methods: Seventeen cases of pancre- atic cancer tissues and 6 normal pancreatic tissues were examined respectively by semiquantitative reverse transeriptase polymerase chain reaction (RT-PCR) to detect the Smad6 and Smad7 mRNA expression. Results: The expression levels of Smad6 and Smad7 mRNA in pancreatic cancer tissues were significantly higher than those in normal pancreatic tissues (1. 15±0. 51 vs. 0. 47±0. 18 and 1. 44±0. 84 vs. 0. 39±0. 29, respectively, P0. 05). No association was found between Smad6. Smad7 expression and patients' clinicopathological characteristics, such as gender, age, TNM stage and tumor differentia- tion. Conclusions: Smad6 and Smad7 are overexpressed in pancreatic cancer tissues, they may serve as oncogenes and are involved in the development and progression of pancreatic cancer.
What problem does this paper attempt to address?